CANCER, LUNG

This early-phase trial tests CPO301, a drug that delivers a cancer-killing agent directly to tumor cells, in adults with advanced solid tumors (including lung cancer) that have not responded to other treatments. The main goals are to find a safe dose and check for early signs of …

This study is testing a personalized radiation approach called PULSAR for people with lung cancer or lung metastases located in the central chest area. The goal is to see if this method can safely treat these hard-to-reach tumors without losing effectiveness. About 30 adults with…

This study tests a special program designed to help lung cancer survivors living in rural areas feel better and manage their health. About 300 survivors will either join the program or receive standard information. The goal is to see if the program improves quality of life and he…

This study looks at whether special beauty care (called socio-aesthetics) can improve quality of life for adults with lung, breast, colon, or prostate cancer who are getting chemotherapy. About 400 participants will either receive these beauty treatments or use skin products on t…

This study is testing whether an artificial intelligence tool can help match cancer patients to clinical trials they might be eligible for. Researchers will enroll up to 50,000 people with various types of cancer and use the AI to suggest trials. The goal is to see if this approa…

This study is looking for tiny molecules in the blood, called microRNAs, that might be linked to nerve damage caused by chemotherapy. Researchers will study 90 people with lung or colon cancer who are receiving specific chemo drugs. The goal is to find a way to predict or detect …